1237 related articles for article (PubMed ID: 16351799)
21. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
22. [Survival outcomes of T-cell non-Hodgkin's lymphoma: a report of 111 cases].
Huang Y; Lin TY; Wu QL; Su ZL; Huang HQ; Xia ZJ; Sun XF; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Apr; 24(4):470-4. PubMed ID: 15820072
[TBL] [Abstract][Full Text] [Related]
23. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
24. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
[TBL] [Abstract][Full Text] [Related]
25. [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].
Huang HQ; Peng YL; Lin XB; Sun XF; Lin TY; Xia ZJ; Li YH; Cai QQ; He YJ; Jiang WQ; Guan ZZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1443-7. PubMed ID: 15566653
[TBL] [Abstract][Full Text] [Related]
26. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma].
Yao B; Li YX; Fang H; Yu ZH; Jin J; Liu XF
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):222-5. PubMed ID: 16875550
[TBL] [Abstract][Full Text] [Related]
28. Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results.
Orlandi E; Lazzarino M; Brusamolino E; Castelli G; Pagnucco G; Morra E; Bernasconi C
Haematologica; 1991; 76(3):204-8. PubMed ID: 1743590
[TBL] [Abstract][Full Text] [Related]
29. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
Guo HY; Zhao XM; Cao JN; Hu XC; Yin JL; Hong XN; Li J
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
Niibe Y; Hayakawa K; Kitano M; Ishiyama H; Nakayama M; Yao K; Okamoto M
Anticancer Res; 2005; 25(6C):4403-6. PubMed ID: 16334116
[TBL] [Abstract][Full Text] [Related]
31. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma.
Lambertenghi Deliliers G; Butti C; Baldini L; Ceriani A; Lombardi F; Luoni M; Montalbetti L; Pavia G; Pinotti G; Pogliani E
Haematologica; 1995; 80(4):318-24. PubMed ID: 7590500
[TBL] [Abstract][Full Text] [Related]
32. [MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].
Fan Y; Huang ZY; Luo LH; Yu HF
Ai Zheng; 2005 Dec; 24(12):1503-6. PubMed ID: 16351801
[TBL] [Abstract][Full Text] [Related]
33. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
Li YX; Yao B; Jin J; Wang WH; Liu YP; Song YW; Wang SL; Liu XF; Zhou LQ; He XH; Lu N; Yu ZH
J Clin Oncol; 2006 Jan; 24(1):181-9. PubMed ID: 16382127
[TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
Li YH; Jiang WQ; Huang HQ; Xu RH; Lin TY; Xia ZJ; He YJ; Guan ZZ
Ai Zheng; 2003 Apr; 22(4):401-3. PubMed ID: 12703998
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy.
Kim K; Chie EK; Kim CW; Kim IH; Park CI
Jpn J Clin Oncol; 2005 Jan; 35(1):1-5. PubMed ID: 15681596
[TBL] [Abstract][Full Text] [Related]
40. [Weekly CHOP chemotherapy in the treatment of intermediate-grade non-Hodgkin's lymphomas--cooperative group study by seven institutes].
Kobayashi M; Sao H; Mizuta S; Kamiya O; Ohara K; Nagata K; Takeyama H; Watanabe E; Yamada H; Mizuno H
Rinsho Ketsueki; 1990 Oct; 31(10):1656-63. PubMed ID: 2255056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]